Skip to main content

Medical Weight Loss

RenewMD Health and Wellness, led by Dr. Nataly Saldana, offers medical weight loss programs utilizing medications like semaglutide and tirzepatide. Semaglutide is a GLP-1 receptor agonist that suppresses appetite and slows gastric emptying, aiding in weight loss. Tirzepatide is a dual GLP-1 and GIP receptor agonist, which may offer enhanced weight loss benefits compared to semaglutide. During consultations, Dr. Saldana discusses these treatment options, considering factors such as diet, exercise, and lab results to tailor a personalized plan. The clinic provides both semaglutide and tirzepatide injections, with pricing starting at $400 for the first month of semaglutide and $425 for tirzepatide.

Renew's Medical Weight Loss Program Benefits:

FDA-Approved Medications

FDA-approved medications such as Semaglutide or Tirzepatide. Semaglutide, a glucagon-like peptide that increases insulin secretion, helps reduce food cravings and enhances feelings of fullness, making it an effective solution for managing obesity. Tirzepatide, a dual-receptor agonist, has been shown to be even more effective for weight loss than Semaglutide, and is administered once a week. Both options are supported by ongoing consultations and a holistic approach to diet and exercise, ensuring you receive the most effective treatment for sustainable weight loss.

Is Medical Weight Loss Right For You?

Medical weight loss could be the right solution for you if you’re struggling with weight management and are seeking a personalized, effective approach. During your consultation, your unique health history, diet, and exercise routine will be carefully reviewed, alongside lab work to assess your overall health.

If you’re committed to improving your health and are looking for a medically supervised weight loss plan, Dr. Saldana’s tailored approach could provide the support and results you’ve been looking for.

FDA-Approved Medication

Semaglutide

Semaglutide is a glucagon-like peptide that increases the recreation of insulin. It is FDA approved for weight management in patients that are obese. This medication helps reduce food craving and increases the feeling of fullness. Price is $400 for the first month and $425 for subsequent months.

Tirzepatide

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It has been shown to be more effective for weight loss compared to semaglutide. Pricing starts at $425 for the first month.